Avalo Therapeutics (AVTX) to Release Quarterly Earnings on Wednesday

Avalo Therapeutics (NASDAQ:AVTX – Get Rating) is set to issue its quarterly earnings data on Wednesday, May 3rd. Avalo Therapeutics Trading Down 2.6 % Shares of AVTX traded down $0.08 during mid-day trading on Tuesday, hitting $3.00. 7,763 shares of the company’s stock were exchanged, compared to its average volume of 26,212. Avalo Therapeutics has […]

Related Keywords

,Securities Exchange Commission ,Avalo Therapeutics Company Profile ,Avalo Therapeutics Inc ,Millennium Management ,Susquehanna International Group ,Renaissance Technologies ,Caissa Capital Management Ltd ,Jefferies Financial Group ,Goldman Sachs Group Inc ,Avalo Therapeutics ,Get Rating ,Therapeutics Trading Down ,Caissa Capital Management ,Exchange Commission ,International Group ,Sachs Group ,Avalo Therapeutics Daily ,Nasdaq Avtx ,Avtx ,Medical ,Earnings ,